APAC Dialyzer Market

APAC Dialyzer Market Size (2023 to 2028)

The APAC dialyzer Market was worth USD 827.22 million in 2023 and is estimated to be growing at a CAGR of 8.92%, to reach USD 1268.12 million by 2028.

A dialyzer is a medical device that replaces kidney function by using an artificial membrane to remove excess water and metabolic wastes from the blood. Dialyzers are primarily used by healthcare professionals for haemodialysis.

The significant increase in the elderly population and the frequent occurrence of kidney disorders, notably end-stage renal disease, are the key reasons driving the growth of the APAC dialyzer market. Higher adoption of haemodialysis to treat highly prevalent end-stage renal disease, as well as a faster pace of infrastructure development, providing a favourable environment for the installation of haemodialysis machines in emerging countries, are expected to drive the dialyzer market in the Asia Pacific.

Increased funding for improved dialysis products and services, rising diabetes and hypertension rates, and a lack of kidneys for transplantation are expected to propel the industry forward. Because of the existence of expanding economies, rising healthcare spending, and a constantly growing population, Asia Pacific is considered an emerging market for dialyzers. Diabetic and hypertensive nephropathy are the primary causes of kidney problems, and the increased prevalence of these diseases has fuelled the market need for Dialyzers.

Dialyzers are primarily used by medical practitioners during haemodialysis procedures. Haemodialysis is a treatment that removes waste from the blood of people who have chronic or acute renal failure. The evacuation of waste aids in the patient's electrolyte balance. It also prevents the build-up of salts and wastes in the blood, which could result in poisoning. Factors such as the rise in independent dialysis centres, increased awareness of dialysis treatment methods, reimbursement modifications, and healthcare insurance regulations will all contribute to the Asia Pacific region's dialysis product and service business growth.

The dialyzer market is expected to increase because of technical advances that lead to better acceptance and possibilities in emerging markets. Dialyzers used for home dialysis are expected to expand at the quickest CAGR during the forecast period, due to the implementation of modern dialysis products with better efficiency, which allows patients to choose home dialysis, increasing the growth of the APAC dialyzer market.

However, The APAC dialyzer market is projected to be restrained by rising dialyzer costs and severe regulatory regulations. Furthermore, the APAC dialyzers market is expected to be hampered by an increase in dialyzer reuse. The market's growth is also hampered by complications and dangers associated with haemodialyses, such as severe anaemia and fluid overload.

This research report on the APAC dialyzer market has been segmented and sub-segmented into the following categories:

By Type

• High-Flux
• Low-Flux

By End-User

• In Center Dialyzer
• Home Dialyzer

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand, Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

APAC dialyzer market is going to be expanding due to increased awareness among healthcare professionals, rising healthcare expenditures, improved healthcare infrastructure, and increased medical tourism in the Asia Pacific area. In the Asia Pacific, the incidence and prevalence of chronic kidney failure, as well as the demand for renal replacement therapy, is quickly rising. Infections such as bacterial, mycobacterial, and hepatitis B, among others, are increasing in frequency, contributing to market expansion. According to the International Society of Nephrology, a 52 per cent death rate from acute renal injury infections contributes to the dialysis rate in the Asia Pacific region. In 2020, the dialysis market in Japan generated around USD 6,300.9 million in revenue.

KEY MARKET PLAYERS:

Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Medtronic Plc, JMS Co.Ltd., Kawasumi Laboratories Inc., Fresenius Medical Care AG and Co. KGaA, Nikkiso Co. Ltd., Nipro Corp. and Toray Industries Inc. are some of the key players operating in the APAC dialyzer market profiled in this report.